Eine zielgenaue Bewerbung für diesen Job — ein maßgeschneiderter Lebenslauf und ein Anschreiben, die genau zur Stellenanzeige passen.
Octapharma Germany is seeking a senior QA professional to act as a Group Subject Matter Expert for GMP regulations and to lead the harmonisation of the Pharmaceutical Quality System. The role involves coordinating cross-site quality initiatives and supporting intersite audits across Europe, with regular travel 5–10 times per year.
The ideal candidate holds a university degree in a relevant scientific field and brings 10+ years of pharmaceutical QA experience, including implementation of CAPA,
Job-ID: 63605 Location: Wien, AUT; Lingolsheim, FRA; Springe, DEU; Stockholm, SWE Job Level: Professionals Category: Quality Employment Type: Permanent position
Become part of a vital chain and contribute to our common goal of making people’s lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
The position will be filled in Vienna (Austria), Springe (Germany), Stockholm (Sweden) or Lingolsheim (France).
Join us in shaping our vision of providing new health solutions advancing human life.
You will thrive in this role if you enjoy staying close to evolving GMP requirements, turning them into practical actions and working with Quality teams across different sites to maintain a strong and consistent Pharmaceutical Quality System.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Do you have any questions? Then get in touch with your contact person.
Larissa Amling
Octapharma Pharmazeutika Produktionsges.m.b.H.
Oberlaaer Straße 235, 1100 Wien
T: +43 664 789 53 728
Visit our website Octapharma Career and follow us daily on LinkedIn.
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing plasma-derived and recombinant medicines.
Octapharma employs more than 11,000 people worldwide to support the treatment of patients in 120 countries with products in three therapeutic areas: Immunotherapy, Haematology, and Critical Care.
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 200 plasma donation centres across Europe and the US.